Immunic, Inc. (IMUX) stock
IMUXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$7.52+0.19 (+2.59%)
Close on Nov 18, 2026Market cap $102.61MP/E –Yield 0.00%
Immunic market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Immunic's market cap was $110.79M on Nov 11, 2026, against $70.23M a year earlier. Over the last 5 years it ranged from $40.96M to $309.48M, with a median of $98.26M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $110.79M | +110.4% |
| 2025 | Dec 31, 2025 | $52.65M | -41.6% |
| 2024 | Dec 31, 2024 | $90.08M | +34.7% |
| 2023 | Dec 29, 2023 | $66.89M | +56.3% |
| 2022 | Dec 30, 2022 | $42.79M | -83.0% |
| 2021 | Dec 31, 2021 | $251.21M | -20.7% |
| 2020 | Dec 31, 2020 | $316.78M | +224.3% |
| 2019 | Dec 31, 2019 | $97.69M | +1446.9% |
| 2018 | Dec 31, 2018 | $6.31M | -96.9% |
| 2017 | Dec 29, 2017 | $200.91M | +80.7% |
| 2016 | Dec 30, 2016 | $111.18M | -50.0% |
| 2015 | Dec 31, 2015 | $222.52M | -48.8% |
| 2014 | Dec 31, 2014 | $434.60M | – |
See a number that looks wrong?